J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS – Research Report), Amicus (FOLD – Research ...

We recently compiled a list of the 10 Oversold Blue Chip Stocks to Buy Now. In this article, we are going to take a look at ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

We recently compiled a list of the 10 Most Profitable Value Stocks To Invest In. In this article, we are going to take a look ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We recently compiled a list of the 10 Most Profitable Value Stocks To Invest In. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other ...

After a preliminary announcement a few weeks ago that included a CEO change, CVS Health CVS released its full third-quarter earnings results. The firm’s info highlighted weaknesses in its Aetna ...